FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to 4-arylpiperazines and 4-arylpiperidines of the formula (I) where A is N or CH; W is C, SO; R1, R2 - H or C1-4-alkyl; n = 0-4; R3, R4 - H, alkyl, OH or taken in common as oxygen present carbonyl-group; R5 - H, C1-8-alkyl, C1-8-alkoxy-, nitro-, amino-, C1-8-acylamino-group; R6 - H; R7 is O, S if W is C; R7 is O if W is SO (other values see p. 1 of the invention claim) that show inhibitory activity with respect to dopamine-2-receptors. EFFECT: new compounds indicated above, inhibitors of receptors. 35 cl, 8 tbl, 113 ex
Title | Year | Author | Number |
---|---|---|---|
4-PHENYLPIPERAZINE AND 4-PHENYLPIPERIDINE OXIDES, COMPOSITION BASED ON THEREOF AND A METHOD OF INHIBITION OF DOPHAMINE-2 RECEPTORS | 1994 |
|
RU2123001C1 |
METHOD OF PREPARING 3-ARYL-BENZOFURANS | 1994 |
|
RU2132847C1 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
THERAPEUTIC AGENT FOR TREATMENT OF DIABETIC PATIENTS | 1997 |
|
RU2174114C2 |
SUBSTITUTED PYRROLIDINES AS XIa FACTOR INHIBITORS FOR THROMBOEMBOLIC DISEASES TREATMENT | 2013 |
|
RU2636050C2 |
NEW APPLICATION | 2005 |
|
RU2353362C2 |
NOVEL DERIVATIVES OF IMIDAZOLIDINE, THEIR PREPARING AND USING AS VLA-4 ANTAGONIST | 2002 |
|
RU2318815C2 |
SULFUR-CONTAINING PHOSPHONIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1993 |
|
RU2136691C1 |
4-PHENOXY-NICOTANIMIDES OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDES | 2011 |
|
RU2565077C2 |
Authors
Dates
1999-10-20—Published
1992-09-11—Filed